Dare Bioscience, Inc. Interest Payable, Current
Dare Bioscience, Inc. (DARE) had Interest Payable, Current of $79.03 thousand as of 2017-06-30, per its 8-K/A filed 2017-10-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2018-03-28
- 2017-06-30: Interest Payable, Current $79.03K.
- 2016-12-31: Interest Payable, Current $45.06K; Interest Payable, Current as first filed $82.00K.
- 2016-09-30: Interest Payable, Current $92.00K.
- 2016-06-30: Interest Payable, Current $104.00K.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2017-06-30 | $79.03K 8-K/A · filed 2017-10-02 | |
| 2016-12-31 | $45.06K 10-K · filed 2018-03-28 | $82.00K 10-K · filed 2017-03-31 |
| 2016-09-30 | $92.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $104.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $116.00K 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $2.96K 8-K/A · filed 2017-10-02 | $136.00K 10-K · filed 2016-03-10 |
| 2015-09-30 | $91.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $91.00K 10-Q · filed 2015-08-06 | |
| 2014-12-31 | $574.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |